ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Straus asks to “Set Record Straight”

September 2, 1988

NCI to Support Research and Development Of Image Guided Therapy for Prostate Cancer

July 16, 1999

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

April 25, 2013

Senate Approves $1 Billion For NCI

July 27, 1979

Some Long-Term Survivors At Higher Risk Of Stroke

November 24, 2006

Study tests a “truth” in radiation oncology, raises questions about anemia treatment.

October 24, 2003